{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:04:25Z","timestamp":1790802265000,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.isci.2024.109225","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:15:33Z","timestamp":1707974133000},"page":"109225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity"],"prefix":"10.1016","volume":"27","author":[{"given":"Alexandra E.","family":"Oppong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Coelewij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Martin-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty E.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"D\u00f6nnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Nytrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Pineda-Torra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-3396","authenticated-orcid":false,"given":"Elizabeth C.","family":"Jury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109225_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.isci.2024.109225_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.109225_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple Sclerosis: An Immune or Neurodegenerative Disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.isci.2024.109225_bib4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.109225_bib5","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.isci.2024.109225_bib6","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.109225_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/1352458517709619","article-title":"Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study","volume":"24","author":"Kappos","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2024.109225_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bj.2022.01.004","article-title":"Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances","volume":"45","author":"Liu","year":"2022","journal-title":"Biomed. J."},{"key":"10.1016\/j.isci.2024.109225_bib9","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/ijms24021448","article-title":"A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review","volume":"24","author":"Chiricosta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.109225_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1352458519876020","article-title":"Metabolomics in multiple sclerosis disease course and progression","volume":"26","author":"Bhargava","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2024.109225_bib11","article-title":"Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism","volume":"2","author":"Fitzgerald","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2024.109225_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biocel.2017.07.004","article-title":"Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis","volume":"93","author":"Poddighe","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.isci.2024.109225_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40478-017-0495-8","article-title":"Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease","volume":"5","author":"Jurynczyk","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.isci.2024.109225_bib14","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1212\/WNL.0000000000000905","article-title":"A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis","volume":"83","author":"Dickens","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2024.109225_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fnhum.2018.00226","article-title":"Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring","volume":"12","author":"Stoessel","year":"2018","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.isci.2024.109225_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102243","article-title":"Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases","volume":"44","author":"Nali","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.isci.2024.109225_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.918041","article-title":"Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod","volume":"16","author":"Kihara","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.isci.2024.109225_bib18","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1073\/pnas.1821306116","article-title":"Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis","volume":"116","author":"Voskuhl","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.109225_bib19","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/brain\/awaa084","article-title":"NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients","volume":"143","author":"Malhotra","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.isci.2024.109225_bib20","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.120.315321","article-title":"Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus","volume":"41","author":"Coelewij","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.isci.2024.109225_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-0716-0239-3_17","article-title":"Using MetaboAnalyst 4.0 for Metabolomics Data Analysis, Interpretation, and Integration with Other Omics Data","volume":"2104","author":"Chong","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2024.109225_bib22","doi-asserted-by":"crossref","DOI":"10.2196\/21798","article-title":"AutoScore: A Machine Learning-Based Automatic Clinical Score Generator and Its Application to Mortality Prediction Using Electronic Health Records","volume":"8","author":"Xie","year":"2020","journal-title":"JMIR Med. Inform."},{"key":"10.1016\/j.isci.2024.109225_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fneur.2014.00250","article-title":"Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis","volume":"5","author":"Mathur","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.isci.2024.109225_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40478-015-0261-8","article-title":"Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions","volume":"3","author":"Nijland","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.isci.2024.109225_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11120812","article-title":"Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis","volume":"11","author":"Yoon","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.isci.2024.109225_bib26","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s12035-016-9846-x","article-title":"Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2024.109225_bib27","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","article-title":"Activation of Necroptosis in Multiple Sclerosis","volume":"10","author":"Ofengeim","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2024.109225_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.isci.2024.109225_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187215","article-title":"Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner","volume":"12","author":"Honorat","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.109225_bib30","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1007\/s00018-020-03733-2","article-title":"An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview","volume":"78","author":"Zahoor","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2024.109225_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.574133","article-title":"Metabolomic Biomarkers of Multiple Sclerosis: A Systematic Review","volume":"7","author":"Porter","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2024.109225_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2123265119","article-title":"Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target","volume":"119","author":"Zahoor","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.109225_bib33","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.109225_bib34","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200025","article-title":"Toward Precision Phenotyping of Multiple Sclerosis","volume":"9","author":"Pitt","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.isci.2024.109225_bib35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1021\/acs.jproteome.8b00809","article-title":"Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults","volume":"18","author":"Dayon","year":"2019","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.isci.2024.109225_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117471","article-title":"Biochemical biomarkers for multiple sclerosis","volume":"548","author":"Maroto-Garc\u00eda","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2024.109225_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00338","article-title":"Neurofilament Light Chain as a Biomarker in Multiple Sclerosis","volume":"10","author":"Varhaug","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.isci.2024.109225_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33077-8","article-title":"Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy","volume":"8","author":"L\u00f6tsch","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109225_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mrc.3915","article-title":"A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance","volume":"51","author":"Mehrpour","year":"2013","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.isci.2024.109225_bib40","article-title":"Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.109225_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69119-3","article-title":"A blood-based metabolomics test to distinguish relapsing-remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application","volume":"10","author":"Yeo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109225_bib42","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","article-title":"Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank","volume":"14","author":"Julkunen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109225_bib43","article-title":"Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts","volume":"10","author":"Tikkanen","year":"2021","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.isci.2024.109225_bib44","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1212\/NXI.0000000000000185","article-title":"(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis","volume":"3","author":"Cocco","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.isci.2024.109225_bib45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s13311-019-00721-8","article-title":"Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by (1)H-NMR Spectroscopy","volume":"16","author":"Lorefice","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.isci.2024.109225_bib46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/jcbfm.2013.87","article-title":"Ketosis proportionately spares glucose utilization in brain","volume":"33","author":"Zhang","year":"2013","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.isci.2024.109225_bib47","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41593-022-01097-3","article-title":"Identification of early neurodegenerative pathways in progressive multiple sclerosis","volume":"25","author":"Kaufmann","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.isci.2024.109225_bib48","doi-asserted-by":"crossref","first-page":"e8124","DOI":"10.15252\/msb.20178124","article-title":"Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets","volume":"14","author":"Argelaguet","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2024.109225_bib49","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/bioinformatics\/bty1054","article-title":"DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays","volume":"35","author":"Singh","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.109225_bib50","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jpha.2023.06.011","article-title":"Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective","volume":"13","author":"O'Connor","year":"2023","journal-title":"J.\u00a0Pharm. Anal."},{"key":"10.1016\/j.isci.2024.109225_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2024.109225_bib52","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3389\/fimmu.2020.01527","article-title":"Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFN\u03b2","volume":"11","author":"Waddington","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2024.109225_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99274","article-title":"Monocyte NOTCH2 expression predicts IFN-\u03b2 immunogenicity in multiple sclerosis patients","volume":"3","author":"Adriani","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2024.109225_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.720694","article-title":"Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2024.109225_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102932","article-title":"Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study","volume":"58","author":"Eriksen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2024.109225_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103257","article-title":"Sex hormones drive changes in lipoprotein metabolism","volume":"24","author":"Robinson","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2024.109225_bib57","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1260793","article-title":"Genomic variation. Impact of regulatory variation from RNA to protein","volume":"347","author":"Battle","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.109225_bib58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","article-title":"The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research","volume":"1277","author":"Emwas","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2024.109225_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103088","article-title":"The role of cholesterol metabolism in multiple sclerosis: From molecular pathophysiology to radiological and clinical disease activity","volume":"21","author":"Lorincz","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2024.109225_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.639757","article-title":"Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?","volume":"12","author":"Pineda-Torra","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2024.109225_bib61","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1194\/jlr.M072751","article-title":"Serum lipid profile changes predict neurodegeneration in interferon-\u03b21a-treated multiple sclerosis patients","volume":"58","author":"Uher","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.109225_bib62","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1177\/1352458514533162","article-title":"An adverse lipid profile is associated with disability and progression in disability, in people with MS","volume":"20","author":"Tettey","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2024.109225_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35232-7","article-title":"Lipoprotein markers associated with disability from multiple sclerosis","volume":"8","author":"Gafson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109225_bib64","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","article-title":"Defective cholesterol clearance limits remyelination in the aged central nervous system","volume":"359","author":"Cantuti-Castelvetri","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.109225_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/srep43410","article-title":"Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL","volume":"7","author":"Jorissen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109225_bib66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12974-022-02502-1","article-title":"Fatty acids role in multiple sclerosis as \u201cmetabokines\u201d","volume":"19","author":"Yu","year":"2022","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.isci.2024.109225_bib67","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1212\/WNL.0000000000207459","article-title":"Association of Arachidonic Acid\u2013Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis","volume":"101","author":"Broos","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2024.109225_bib68","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3324\/haematol.2019.219519","article-title":"Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction","volume":"105","author":"Gijs","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2024.109225_bib69","series-title":"Multiple Sclerosis: Perspectives in Treatment and Pathogenesis","article-title":"Pathogenesis and Progression of Multiple Sclerosis: The Role of Arachidonic Acid\u2013Mediated Neuroinflammation","author":"Palumbo","year":"2017"},{"key":"10.1016\/j.isci.2024.109225_bib70","first-page":"866","article-title":"Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study","volume":"266","author":"Jakimovski","year":"2019","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.isci.2024.109225_bib71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ene.13769","article-title":"Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study","volume":"26","author":"Jakimovski","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.isci.2024.109225_bib72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11910-021-01143-w","article-title":"Dietary Insights in Neurological Diseases","volume":"21","author":"Ram\u00edrez-Salazar","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.isci.2024.109225_bib73","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","article-title":"Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial","volume":"383","author":"Chataway","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.109225_bib74","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1073\/pnas.1818978116","article-title":"Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis","volume":"116","author":"Eshaghi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.109225_bib75","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12883-015-0495-x","article-title":"Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis","volume":"15","author":"Gurevich","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.isci.2024.109225_bib76","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ene.13565","article-title":"Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis","volume":"25","author":"Koch","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.isci.2024.109225_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: An R package for \u2018omics feature selection and multiple data integration","volume":"13","author":"Rohart","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.isci.2024.109225_bib82","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2024.109225_bib83","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109225_bib84","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web\u00a0tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109225_bib92","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.isci.2024.109225_bib95","first-page":"D845","article-title":"The DisGeNET\u00a0knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109225_bib87","first-page":"1","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J.\u00a0Stat. Softw."},{"key":"10.1016\/j.isci.2024.109225_bib88","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1198\/1061860032238","article-title":"Logic regression","volume":"12","author":"Ruczinski","year":"2003","journal-title":"J.\u00a0Comput. Graph Stat."},{"key":"10.1016\/j.isci.2024.109225_bib89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the Caret Package","volume":"28","author":"Kuhn","year":"2008","journal-title":"Journal of statistical software"},{"key":"10.1016\/j.isci.2024.109225_bib90","series-title":"caTools: Tools: Moving Window Statistics, GIF, Base64, ROC AUC, Etc","author":"Tuszynski","year":"2021"},{"key":"10.1016\/j.isci.2024.109225_bib91","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1541-0420.2011.01616.x","article-title":"ggplot2: Elegant Graphics for Data Analysis by WICKHAM","volume":"67","author":"Wilkinson","year":"2011","journal-title":"Biometrics"},{"key":"10.1016\/j.isci.2024.109225_bib93","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"circlize Implements and enhances circular visualization in R","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.109225_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121945","article-title":"cocor: A Comprehensive Solution for the Statistical Comparison of Correlations","volume":"10","author":"Diedenhofen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.109225_bib96","author":"Blighe"},{"key":"10.1016\/j.isci.2024.109225_bib77","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2024.109225_bib78","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1021\/acs.jproteome.9b00343","article-title":"Effect of Repeated Freeze-Thaw Cycles\u00a0on\u00a0NMR-Measured Lipoproteins\u00a0and\u00a0Metabolites in Biofluids","volume":"18","author":"Wang","year":"2019","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.isci.2024.109225_bib79","series-title":"picard: A Set of Command Line Tools (In Java) for Manipulating High-Throughput Sequencing\u00a0(HTS) Data and Formats Such as SAM\/BAM\/CRAM and VCF","year":"2019"},{"key":"10.1016\/j.isci.2024.109225_bib80","series-title":"STAR: RNA-seq aligner","author":"Dobin","year":"2022"},{"key":"10.1016\/j.isci.2024.109225_bib81","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224004462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224004462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:48:21Z","timestamp":1753868901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224004462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2589004224004462"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109225","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109225"}}